Enzyre
Enzyre is a developer of diagnostic technology.
Total raised
€13M
€13,400,000
Funding rounds
2
Investors
7
distinct backers
Active since
2020-07
latest 2022-11
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood36
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 10y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-02 | Series A | €12M | Demcon Investment,Dutch Government,i&i Biotech Fund,Novalis Biotech,Oost NL,Takeda Ventures | View deal → |
| 2020-07-27 | Other | €1.4M | Novalis Biotechnology Incubation | View deal → |
Investors
7Related news
- Dutch startup Enzyre snaps €12M for empowering haemophilia patients to optimise treatment themselvestechfundingnews.com · 2022-11
- finsmes.com
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- Roivant Sciences€1.2BSwitzerland · Healthtech